Key Steps to Optimizing GDMT in Heart Failure Key Steps to Optimizing GDMT in Heart Failure
Dr Biykem Bozkurt outlines strategies for achieving guideline-directed medical therapy optimization.American College of Cardiology & Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - August 2, 2023 Category: Cardiology Tags: Cardiology Commentary Source Type: news
Leukocyte Telomere Length Tied to Cardiac Function, HF Risk Leukocyte Telomere Length Tied to Cardiac Function, HF Risk
Longer leukocyte telomere length is associated with cardiac size, function, and lower heart failure risk in a middle-aged population.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 1, 2023 Category: Consumer Health News Tags: Cardiology News Source Type: news
New artificial intelligence program could help treat hypertension
For the nearly half of Americans with hypertension, it ' s a potential death sentence; it increases the risk of stroke and chronic heart failure. While it ' s relatively easy to prevent or moderate if caught early — eat well, exercise more, consume less… (Source: NSF News)
Source: NSF News - August 1, 2023 Category: Science Authors: NSF Source Type: news
Ultromics highlights EchoGo clinical results
Ultromics is highlighting clinical results for its EchoGo Heart Failure softwar...Read more on AuntMinnie.comRelated Reading:
Ultromics secures FDA breakthrough device designation for cardiac AI
Ultromics secures FDA clearance for heart failure AI software
Ultromics joins initiative researching heart failure syndrome
Caption Health, Ultromics combine efforts in cardiac ultrasound
Ultromics' AI software gets thumbs-up from regulators (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 31, 2023 Category: Radiology Source Type: news
Prescribing patterns of fall risk-increasing drugs in older adults hospitalized for heart failure - Liu E, Nahid M, Musse M, Chen L, Hilmer SN, Zullo A, Kwak MJ, Lachs M, Levitan EB, Safford MM, Goyal P.
BACKGROUND: Older adults hospitalized for heart failure (HF) are at risk for falls after discharge. One modifiable contributor to falls is fall risk-increasing drugs (FRIDs). However, the prevalence of FRIDs among older adults hospitalized for HF is unknow... (Source: SafetyLit)
Source: SafetyLit - July 31, 2023 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
Higher Step Counts Tied to Fewer Symptoms in HF Higher Step Counts Tied to Fewer Symptoms in HF
Daily step counts between 1000 and 5000 are significantly associated with lower rates of heart failure symptoms and physical limitations.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - July 28, 2023 Category: Cardiology Tags: Cardiology News Source Type: news
Increasing Daily Step Counts Tied to Improved Heart Failure Outcomes
FRIDAY, July 28, 2023 -- Increasing step counts are significantly associated with improvements in health status among patients with heart failure, according to a study published online July 26 in JACC: Heart Failure.
Jessica R. Golbus, M.D., from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 28, 2023 Category: Pharmaceuticals Source Type: news
Step Counts Aren't Just for the Healthy: They Also Help Heart Failure Patients
WEDNESDAY, July 26, 2023 -- Wearable devices like smartwatches continually track physical activity, urging folks to take more daily steps for their health.
Now, a new study suggests this gentle technological nagging could be of great benefit to... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 26, 2023 Category: General Medicine Source Type: news
Increased step count linked to better health for people with heart failure
Clinicians examining data from wearable devices that track steps per day found people with heart failure experienced fewer health limitations with increased mobility. (Source: Health News - UPI.com)
Source: Health News - UPI.com - July 26, 2023 Category: Consumer Health News Source Type: news
Early or Delayed AF Ablation After HF Hospitalization? Early or Delayed AF Ablation After HF Hospitalization?
Patients with AF discharged from a heart failure (HF) hospitalization showed lower all-cause and HF-related mortality if they underwent ablation within 90 days in a registry study.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - July 24, 2023 Category: Neurology Tags: Cardiology News Source Type: news
Comment on "Exploring the factors associated with decreased dynamic balance ability in older patients with heart failure" - Payal F, Bansari RB, Saveeta F.
[The publisher has not provided an abstract for this article.]
Language: en... (Source: SafetyLit)
Source: SafetyLit - July 24, 2023 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news
Roche enters partnership with Alnylam to co-develop and co-commercialise RNAi therapeutic zilebesiran to treat hypertension in patients with high cardiovascular risk
Partnership combines Roche ’s proven track record of successfully developing and launching innovative medicines worldwide withAlnylam ’s leadership in RNAi therapeuticsZilebesiran, a Phase 2 RNAi therapeutic, has best-in-disease potential for patients with hypertension at high risk of cardiovascular morbidity and mortality, by robustly and durably lowering blood pressureHypertension, the leading cause of cardiovascular disease, affects more than 1.2 billion adults worldwide. While several therapies exist, a significant unmet need, especially for high risk patients, remains.1Basel, 24 July 2023 - Roche (SIX: RO, ROG; OT...
Source: Roche Media News - July 24, 2023 Category: Pharmaceuticals Source Type: news
Roche enters partnership with Alnylam to co-develop and co-commercialise RNAi therapeutic zilebesiran to treat hypertension in patients with high cardiovascular risk
Partnership combines Roche ’s proven track record of successfully developing and launching innovative medicines worldwide withAlnylam ’s leadership in RNAi therapeuticsZilebesiran, a Phase 2 RNAi therapeutic, has best-in-disease potential for patients with hypertension at high risk of cardiovascular morbidity and mortality, by robustly and durably lowering blood pressureHypertension, the leading cause of cardiovascular disease, affects more than 1.2 billion adults worldwide. While several therapies exist, a significant unmet need, especially for high risk patients, remains.1Basel, 24 July 2023 - Roche (SIX: RO, ROG; OT...
Source: Roche Investor Update - July 24, 2023 Category: Pharmaceuticals Source Type: news
How to Manage Heart Failure With Preserved Ejection Fraction How to Manage Heart Failure With Preserved Ejection Fraction
This review provides an up-to-date framework for diagnosis and evidence-based treatment of patients with heart failure with preserved ejection fraction.JACC: Heart Failure (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 24, 2023 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news
Can Patent Foramen Ovales Cause Problems?
Discussion
During fetal development, the heart primum and secundum septa grow and overlap leaving a small but important channel between the two atria. The foramen ovale is a flap valve moving blood from the right atrium into the left atrium directly and bypassing the high pressure pulmonary system. After birth and breathing air, the neonate’s lungs open up and the pulmonary vascular resistance decreases. The left atrium now has a relatively higher pressure than the right atria, and therefore pressure on the flap valve closes the foramen ovale. Usually within 6-12 months, the fusion of the primum and secundum of the f...
Source: PediatricEducation.org - July 24, 2023 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
